What was the market valuation of the stem cell-banking market in 2024?

The market valuation was $675.0 Million in 2024. Read More

What is the projected market valuation for 2035?

The projected market valuation for 2035 is $2612.5 Million. Read More

What is the expected CAGR for the stem cell-banking market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 13.09%. Read More

Which segment had the highest valuation in 2024?

In 2024, the Adult Stem Cells segment had the highest valuation at $225.0 Million. Read More

What are the key players in the stem cell-banking market?

Key players include Cord Blood Registry, Viacord, Cryo-Cell International, LifebankUSA, StemCyte, Cells4Life, Cryo-Save, and Reprocell. Read More

What is the valuation range for Umbilical Cord Blood from 2025 to 2035?

The valuation range for Umbilical Cord Blood is projected to be between $135.0 Million and $525.0 Million. Read More

How much is the Hematopoietic Stem Cells segment expected to grow by 2035?

The Hematopoietic Stem Cells segment is expected to grow to a valuation of $600.0 Million by 2035. Read More

What is the projected valuation for the Tissue Preservation segment in 2035?

The projected valuation for the Tissue Preservation segment in 2035 is $632.5 Million. Read More

Which end user segment is expected to have the highest valuation by 2035?

The Pharmaceutical Companies segment is expected to have the highest valuation at $1137.5 Million by 2035. Read More

What is the valuation range for Mesenchymal Stem Cells from 2025 to 2035?

The valuation range for Mesenchymal Stem Cells is projected to be between $200.0 Million and $800.0 Million. Read More

South America Stem Cell Banking Market

ID: MRFR/MED/49489-HCR

200 Pages

Nidhi Mandole

Last Updated: February 06, 2026

South America Stem Cell Banking Market Research Report By Cell Type (Umbilical Cord Stem Cells, Adult Stem Cells, Embryonic Stem Cells), By Bank Type (Private Banks, Public Banks, Hybrid Banks), By Application (Thalassemia, Cerebral Palsy, Diabetes, Leukemia, Autism), and By Regional (Brazil, Mexico, Argentina, Rest of South America) -Forecast to 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Stem Cell Source (USD Million)
  1. 4.1.1 Umbilical Cord Blood
  2. 4.1.2 Adult Stem Cells
  3. 4.1.3 Embryonic Stem Cells
  4. 4.1.4 Perinatal Stem Cells
2. 4.2 Medical Device, BY Cell Type (USD Million)
  1. 4.2.1 Hematopoietic Stem Cells
  2. 4.2.2 Mesenchymal Stem Cells
  3. 4.2.3 Neural Stem Cells
  4. 4.2.4 Induced Pluripotent Stem Cells
3. 4.3 Medical Device, BY Storage Type (USD Million)
  1. 4.3.1 Cryopreservation
  2. 4.3.2 Stem Cell Culture
  3. 4.3.3 Tissue Preservation
4. 4.4 Medical Device, BY End User (USD Million)
  1. 4.4.1 Hospitals
  2. 4.4.2 Research Institutions
  3. 4.4.3 Biotechnology Companies
  4. 4.4.4 Pharmaceutical Companies
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Cord Blood Registry (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Viacord (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Cryo-Cell International (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 LifebankUSA (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 StemCyte (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Cells4Life (GB)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Cryo-Save (NL)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Reprocell (JP)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY STEM CELL SOURCE
3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY CELL TYPE
4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY STORAGE TYPE
5. 6.5 SOUTH AMERICA MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
12. 6.12 MEDICAL DEVICE, BY STEM CELL SOURCE, 2024 (% SHARE)
13. 6.13 MEDICAL DEVICE, BY STEM CELL SOURCE, 2024 TO 2035 (USD Million)
14. 6.14 MEDICAL DEVICE, BY CELL TYPE, 2024 (% SHARE)
15. 6.15 MEDICAL DEVICE, BY CELL TYPE, 2024 TO 2035 (USD Million)
16. 6.16 MEDICAL DEVICE, BY STORAGE TYPE, 2024 (% SHARE)
17. 6.17 MEDICAL DEVICE, BY STORAGE TYPE, 2024 TO 2035 (USD Million)
18. 6.18 MEDICAL DEVICE, BY END USER, 2024 (% SHARE)
19. 6.19 MEDICAL DEVICE, BY END USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY STEM CELL SOURCE, 2025-2035 (USD Million)
  2. 7.2.2 BY CELL TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY STORAGE TYPE, 2025-2035 (USD Million)
  4. 7.2.4 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South America South America Stem Cell Banking Market Segmentation

South America Stem Cell Banking Market By Stem Cell Source (USD Million, 2025-2035)

Umbilical Cord Blood
Adult Stem Cells
Embryonic Stem Cells
Perinatal Stem Cells

South America Stem Cell Banking Market By Cell Type (USD Million, 2025-2035)

Hematopoietic Stem Cells
Mesenchymal Stem Cells
Neural Stem Cells
Induced Pluripotent Stem Cells

South America Stem Cell Banking Market By Storage Type (USD Million, 2025-2035)

Cryopreservation
Stem Cell Culture
Tissue Preservation

South America Stem Cell Banking Market By End User (USD Million, 2025-2035)

Hospitals
Research Institutions
Biotechnology Companies
Pharmaceutical Companies

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”